Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
84 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
SPICA THERAPEUTICS from Antwerpen, company number BE1012800853, closed financial year 2025 with a result of € -2.7 million after tax. For that financial year SPICA THERAPEUTICS recorded a gross margin of € -1 million and equity of € 6.2 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.
€ 6.2 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.7 million
Profit after tax over the fiscal year.
€ 996,528
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.7 million.
People and assets in 2025
€ 37,429
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,397
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.1 million
Supplier invoices still open on the last day of the fiscal year.
€ 6,358
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to SPICA THERAPEUTICS?
What happened at SPICA THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Debora Dumont Management Company CommV stepped down as director. NBB
- Participatiemaatschappij Vlaanderen NV stepped down as director. NBB
- bioskills BV stepped down as director. NBB
- TRIANGULATE GmbH Buitenlandse entiteit stepped down as director. NBB
- QBIC VENTURE PARTNERS III NV stepped down as director. NBB
- Impala Consulting CommV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.7 million. Source: NBB ↗
- Debora Dumont Management Company CommV became a director. NBB
A new publication or filing at SPICA THERAPEUTICS? We notify you, reason included.
Follow SPICA THERAPEUTICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of BIOQUBE FACTORY FUND I, Flanders Future Techfund, QBIC III FUND comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SPICA THERAPEUTICSThe shares are held by BIOQUBE FACTORY FUND I (42.2%), Flanders Future Techfund (17.7%) and QBIC III FUND (7.1%). It owns 100% of OncoSpear ApS itself.
Directors
According to the 2025 annual accounts
Debora Dumont Management Company CommV
Director · represented by Debora Dumont
Also active at: BIOQUBE VENTURES, BQV Partners
since 2025 · until 2031
Participatiemaatschappij Vlaanderen NV
Director · represented by Bart De Taeye
Also active at: VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK, Arts Gebroeders immobilière, BEDRIJVENCENTRUM VILVOORDE, BIOTECH FONDS VLAANDEREN, MAISON DE LA RADIO FLAGEY, HERTECANT FLANGES, Site-Ontwikkeling Vlaanderen, SUSTAINABLE ENERGY VENTURES +136 more
since 2025 · until 2031
since 2025 · until 2031
TRIANGULATE GmbH Buitenlandse entiteit
Director · represented by James Rush
since 2025 · until 2031
Director · represented by Steven Leuridan
Also active at: RheaVita, VoxelSensors, AnimAb, AmphiStar, weave.ly, Swave, QBIC III FUND, THERAtRAME +2 more
since 2025 · until 2031
Director · represented by Alexander Demoulin
since 2025 · until 2031
Shareholders
Participations
OncoSpear ApS
100%
Establishments
Establishment units
Physical locations of this company
Uitbreidingstraat 66 box 31
2600 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 84 companies are registered at this address.
All companies at this address →VTG Rail Logistics Belgium
€ 729 gross margin · 2026
LOGWIN AIR + OCEAN BELGIUM
€ 1.5 million gross margin · 2025
KIWI'S
€ 133,528 gross margin · 2025
C & Q-INVEST
€ -91,038 gross margin · 2024
ANGLO - BELGE SPECIAL RISKS
€ 495,943 gross margin · 2025
+79 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1012.800.853
- VAT number
- BE 1012.800.853
- Registered office
- Uitbreidingstraat 66 bus 31, 2600 Antwerpen
- Names & denominations
- SPICA THERAPEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 August 2024
- Peppol
- Active · Active since 25 Nov 2024
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van overige farmaceutische producten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van geneesmiddelen
Vervaardiging van farmaceutische grondstoffen
Overige gespecialiseerde wetenschappelijke en technische activiteiten